1. Home
  2. ATEN vs IDYA Comparison

ATEN vs IDYA Comparison

Compare ATEN & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo A10 Networks Inc.

ATEN

A10 Networks Inc.

HOLD

Current Price

$37.02

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$37.97

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATEN
IDYA
Founded
2004
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.6B
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
ATEN
IDYA
Price
$37.02
$37.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
16
Target Price
$26.33
$52.86
AVG Volume (30 Days)
1.2M
1.6M
Earning Date
04-28-2026
05-06-2026
Dividend Yield
0.90%
N/A
EPS Growth
N/A
61.90
EPS
0.17
N/A
Revenue
$235,429,000.00
$218,710,000.00
Revenue This Year
$13.02
N/A
Revenue Next Year
$10.82
$201.05
P/E Ratio
$214.82
N/A
Revenue Growth
2.36
3024.43
52 Week Low
$16.52
$21.33
52 Week High
$38.39
$40.58

Technical Indicators

Market Signals
Indicator
ATEN
IDYA
Relative Strength Index (RSI) 69.62 63.66
Support Level $17.10 $29.51
Resistance Level N/A $38.17
Average True Range (ATR) 1.48 1.87
MACD 0.10 0.46
Stochastic Oscillator 77.76 73.73

Price Performance

Historical Comparison
ATEN
IDYA

About ATEN A10 Networks Inc.

A10 Networks Inc is a provider of secure application and network infrastructure solutions for enterprises and service providers across on-premises, hybrid cloud, and distributed environments. The company's offerings include application delivery and traffic management, distributed denial-of-service (DDoS) protection, application and API security, and centralized management. It serves customers across multiple industries, including telecommunications, technology, financial services, public sector, industrial, retail, gaming, and education. The majority of the company's revenue is derived from the sale of secure networking and cybersecurity solutions and related maintenance and support services.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: